Studying mice, scientists at Washington University School of Medicine in St. Louis have identified a neural circuit in the retina that carries signals enabling the eye to detect movement. The finding could help in efforts to build artificial retinas for people who have suffered vision loss.
A miniature version of the University of Iowa’s advanced driving simulator will participate in a clinical trial later this year to assess a patient’s driving ability after cataract surgery.
A series of immersive virtual reality experiments has confirmed that the human brain’s internal navigation system works in the same fashion as the grid cell system recently found in other mammals.
To observe Cataract Awareness Month in June, ophthalmologists from New York Eye and Ear Infirmary of Mount Sinai (NYEE) and The Mount Sinai Hospital (MSH) – both part of the Mount Sinai Health System – are offering prevention tips and raising awareness of options for early detection and effective treatment.
Trending news releases with the most views in a single day. Topics include: melanoma, relationships, color blindness, kidney replacement, oceanography, supercomputers, awards/honors.
A rare eye disorder marked by color blindness, light sensitivity, and other vision problems can result from a newly discovered gene mutation identified by an international research team, including scientists from Columbia University Medical Center (CUMC). The findings, which were published today in the online edition of Nature Genetics, could lead to new, targeted treatments for this form of color blindness.
People with achromatopsia, an inherited eye disorder, see the world literally in black and white. Worse yet, their extreme sensitivity to light makes them nearly blind in bright sunlight. Now, researchers at University of California, San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health System have identified a previously unknown gene mutation that underlies this disorder.
New York Eye and Ear Infirmary of Mount Sinai (NYEE) joins with the International Orthoptic Association (IOA) to observe June 1st as World Orthoptics Day.
Using high-precision genetic tests to differentiate the thousands of bacteria that make up the human microbiome, researchers at NYU Langone Medical Center suggest that they have found a possible — and potentially surprising — root cause of the increased frequency of certain eye infections among contact lens wearers.
Much like the automatic focus of a camera, our eyes and brains must constantly recalibrate so that we can get a clear view of the changing—and always moving—world around us. Two studies funded by the National Eye Institute (NEI) show how the circuitry for this eye-brain coordination is assembled during early embryonic development.
Trending news releases with the most views in a single day. Topics include: genetics and cancer, diabetes and blindness, nanotech, engineering, personalized medicine, energy, and e-cigarettes.
Reporting on their study with lab-grown human cells, researchers at The Johns Hopkins University and the University of Maryland say that blocking a second blood vessel growth protein, along with one that is already well-known, could offer a new way to treat and prevent a blinding eye disease caused by diabetes.
Driving down a dimly lit road at midnight can tax even those with 20/20 vision, but according to a recent UC Irvine study, the brain processes the experience no differently than if it were noon. The same study also reveals how quickly the brain adapts to vision loss, contradicting earlier research and opening the door to novel treatments.
Trending news releases with the most views in a single day. Topics include: vision research, DOE research, aging, mental health, children's health, cancer, tick-borne disease, and drone technology.
On May 7, researchers are reporting a case study in which viable Ebola virus was present in the eye’s aqueous humor — the clear fluid in the front of the eye, between the lens and the cornea — 10 weeks after the virus was no longer detectable in the patient’s blood.
Researchers have developed a drug-releasing implant that controls pain and inflammation, eliminating the need for eye drops following cataract surgery. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
A first-of-its-kind stem cell-based treatment for retinitis pigmentosa developed by UC Irvine’s Dr. Henry Klassen, Dr. Jing Yang and colleagues has received consent from the U.S. Food & Drug Administration for use in a clinical trial.
Doctors have developed a new treatment capable of halting the progression of keratoconus, a progressive eye disease that manifests in teenagers. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Just like cameras with an autostabilization feature, our eyes execute an imperceptible reflex that prevents our vision from blurring when we are in motion. But before the reflex can work, the axons of specialized nerve cells must find their way from the retina to the correct part of the brain. New research describes how those axons accomplish this feat.
Researchers are studying ways to get a snapshot of all the genetic material that a single retina cell uses to make proteins, revealing the health of that eye cell. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
An FDA-approved oral medication, 4-phenylbutyrate (PBA), has been found to prevent vision loss in mice with Leber’s congenital amaurosis (LCA). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Trending news releases with the most views in a single day. Topics include: WWII and PTSD, stem cells, cancer, racial segregation, supplements and glaucoma, medical research, cybersecurity, vision research, and physics.
Researchers have developed a mobile app to quickly and conveniently evaluate people for strabismus, a condition involving misalignment of the eyes. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Between-hospital variations in active treatment explain much of the difference in survival rates seen in infants born at 22 to 24 weeks of gestation.
Preterm babies with retinopathy of prematurity (ROP) treated using bevacizumab, a growth inhibitor, have been found to have lower motor scores than babies treated with traditional laser ablation. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Nurses trained to deliver eye injections for patients with the wet form of age-related macular degeneration (AMD) administered the treatments as safely and effectively as doctors, according to a new study. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Researchers have developed a new computer model to describe how cholesterol deposits, known as drusen, behave in the retina in the dry form of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Scientists have found that baicalein significantly lowers eye pressure and may act as an all-natural treatment for glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Scientists have produced crude 3D tissue structures from induced pluripotent stem (iPS) cells under current good manufacturing practices (cGMP), an important step for eventual large-scale use in human patients. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
L-DOPA, a routine drug taken by patients suffering from Parkinson’s disease, has been found to delay the onset of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Researchers have identified a new target for stopping the progressive death of cells in the eye that leads to vision loss in glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Researchers have found that blocking the connections between cells in the retina can prevent toxins in one cell from spreading – and killing – its neighbors. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Col
Paving the way for drug discovery efforts, researchers have found a target that – when inhibited – reduces inflammation associated with vision loss in patients with diabetic retinopathy (DR). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
A new study found that eye drops were just as effective as eye injections for treating the wet form of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Scientists have identified new biomarkers that could distinguish Sjögren’s Syndrome (SS) from other autoimmune diseases in days or weeks, improving on a current time to diagnosis of four-plus years. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo
A new study finds that when cells in the eye do not have enough oxygen, they improperly sort proteins, an issue that has been implicated in age-related macular degeneration (AMD) and Alzheimer’s disease. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Researchers found that 70% of patients received a dose of hydroxychloroquine that exceeded safety guidelines, and can potentially cause vision loss, in an inner city hospital. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Winner of the Best International Abstract Award, Jeffrey V. Rosenfeld, MD, MS, presented his research, The Development of a Wireless Multielectrode Cortical Prosthesis for Restoration of Vision in Blind Individuals.
Patients with acquired immunodeficiency syndrome (AIDS) have a four-fold increase in their risk of developing intermediate-stage age-related macular degeneration (AMD) compared to people of the same age who are not infected with HIV, according to results from the Longitudinal Study of the Ocular Complications of AIDS (LSOCA) presented today at the 2015 ARVO Annual Meeting in Denver, CO.
Scientists suggest exosomes released by the eye help speed up the drainage of fluid — offering another avenue to treat glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Risk of developing age-related macular degeneration higher in patients with AIDS Denver, Colo. – Patients with acquired immunodeficiency syndrome (AIDS) have a four-fold increase in their risk of developing intermediate-stage age-related macular degeneration (AMD) compared to people of the same age who are not infected with HIV, according to results from the Longitudinal Study of the Ocular Complications of AIDS (LSOCA). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Researchers have identified a genetic link between schizophrenia and strabismus, a condition involving misalignment of the eyes. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Researchers have determined that the three-dimensional organization of DNA in photoreceptor cells plays a crucial role in their function. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Gene therapy for Leber congenital amaurosis (LCA), an inherited disorder that causes loss of night- and day-vision starting in childhood, improved patients’ eyesight within weeks of treatment in a clinical trial of 15 children and adults at the Scheie Eye Institute at the Perelman School of Medicine at the University of Pennsylvania. New results involving a subset of patients from the ongoing trial show that these benefits peaked one to three years after treatment and then diminished. The findings are published today in The New England Journal of Medicine.
Leber congenital amaurosis (LCA) is an inherited disorder that causes vision loss starting in childhood. This is the latest report from an ongoing clinical trial of gene therapy for the disorder, funded by the National Eye Institute (NEI), part of the National Institutes of Health.
Investigators have discovered a new class of drugs that may more effectively treat retinoblastoma, a cancer of the retina that develops in children. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Shifting detection to even earlier than currently used tests, scientists have used vection to identify mild glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Researchers have developed a new method of purifying stem cells that is faster, more efficient and less expensive than current methods for treating diseases of the retina. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo. The new stem cell purification process involves growing stem cells on a special chip containing a computer system. Each stem cell is monitored closely, and the lower quality cells are removed as soon as they are identified.
With more than 50 papers and posters, New York Eye and Ear Infirmary of Mount Sinai and Mount Sinai Health System faculty are leading scientific contributors at the 2015 ARVO meeting in Denver, CO.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right